Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Macro Group Pharmaceuticals (Macro Capital) Co Current Ratio?
Macro Group Pharmaceuticals (Macro Capital) CoCAI:MCRO -2.56%38 Current Ratio is 2.97 as of Mar. 2026, which is 59% above its 10-year median of 1.87. GuruFocus rates CAI:MCRO with a GF Score™ of 38/100. The stock has 2 warning signs investors should review. Among 1,993 Consumer Packaged Goods companies, Macro Group Pharmaceuticals (Macro Capital) Co ranks better than 74.91% on this metric.
CAI:MCRO's Current Ratio is ranked better than 74.91% of 1993
companies
in the Consumer Packaged Goods industry
Industry Median: 1.72
vs CAI:MCRO: 2.97
Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Macro Group Pharmaceuticals (Macro Capital) Co Current Ratio Related Terms
Macro Group Pharmaceuticals (Macro Capital) Co Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Macro Group Pharmaceuticals (Macro Capital) Co Current Ratio Chart
Macro Group Pharmaceuticals (Macro Capital) Co Annual Data
Trend
Dec20
Dec21
Dec22
Current Ratio
0.00
2.31
2.00
Macro Group Pharmaceuticals (Macro Capital) Co Quarterly Data
CAI:MCRO vs PG, CL, KVUE: Current Ratio Comparison
For the Household & Personal Products subindustry, Macro Group Pharmaceuticals (Macro Capital) Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Macro Group Pharmaceuticals (Macro Capital) Co Current Ratio vs Consumer Packaged Goods Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) has a Current Ratio of 2.97 as of Mar. 2026. This is 59% above median its historical median of 1.87. Over the past decade, Macro Group Pharmaceuticals (Macro Capital) Co's Current Ratio has ranged from 0.91 to 2.97. According to the industry distribution chart, Macro Group Pharmaceuticals (Macro Capital) Co ranks #500 out of 1993 companies in the Consumer Packaged Goods industry, placing it in the top 25.1%.
Is Macro Group Pharmaceuticals (Macro Capital) Co's Current Ratio too high?
Macro Group Pharmaceuticals (Macro Capital) Co's current Current Ratio of 2.97 is 59% above median its 10-year median of 1.87. Over the past 10 years, this metric has ranged from a low of 0.91 to a high of 2.97. The Consumer Packaged Goods industry median Current Ratio is 1.72. Macro Group Pharmaceuticals (Macro Capital) Co's value of 2.97 is 72.7% above this industry median. Based on the distribution chart, Macro Group Pharmaceuticals (Macro Capital) Co ranks #500 out of 1993 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Macro Group Pharmaceuticals (Macro Capital) Co has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Macro Group Pharmaceuticals (Macro Capital) Co's Current Ratio compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Macro Group Pharmaceuticals (Macro Capital) Co ranks #500 out of 1993 companies for Current Ratio. This puts Macro Group Pharmaceuticals (Macro Capital) Co in the upper half of its industry. The industry median Current Ratio is 1.72. Macro Group Pharmaceuticals (Macro Capital) Co's value of 2.97 is 72.7% above this benchmark. Historically, Macro Group Pharmaceuticals (Macro Capital) Co's own Current Ratio has ranged from 0.91 to 2.97 over the past decade. While the company's 10-year median is 1.87 vs. the industry median of 1.72, Macro Group Pharmaceuticals (Macro Capital) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Consumer Packaged Goods company?
The median Current Ratio among Consumer Packaged Goods companies is 1.72, based on 1,993 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Macro Group Pharmaceuticals (Macro Capital) Co's current Current Ratio of 2.97 is 72.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median Current Ratio is 1.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Macro Group Pharmaceuticals (Macro Capital) Co's current Current Ratio is 2.97, which is 59% above median its own 10-year median of 1.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Macro Group Pharmaceuticals (Macro Capital) Co stock overvalued right now?
Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) has a current Current Ratio of 2.97. The current Current Ratio is 2.97, which is 59% above median its 10-year median of 1.87 and 72.7% above the Consumer Packaged Goods industry median of 1.72. Macro Group Pharmaceuticals (Macro Capital) Co's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO), the current Current Ratio is 2.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Macro Group Pharmaceuticals (Macro Capital) Co is principally engaged in the manufacture and sale of cosmeceutical and ventured into nutraceutical products.
38GF Score
Get the complete analysis for CAI:MCRO
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAI:MCRO has been successfully added to your 
